GLP1.tools

Insulin Glargine Side Effects: The Complete List and How to Handle Them

Quick Answer

The short version: the most common side effects of Insulin Glargine are hypoglycemia, weight gain, injection-site reactions. Serious risks include severe hypoglycemia and diabetic ketoacidosis if dosing is interrupted in T1D. Most common effects are dose-related and improve with time or titration.

Insulin Glargine at a glance:

  • Drug class: Insulin / insulin analog
  • Route: subcutaneous injection (insulin pump or pen); IV in hospital settings
  • Typical frequency: varies — basal once or twice daily; bolus before meals
  • Half-life: varies — minutes for rapid-acting analogs, hours for basal analogs
  • Cash price (US): varies widely; most US insulins are now capped at $35/month for Medicare beneficiaries

Insulin Glargine's side-effect profile follows the same general pattern as other insulin / insulin analogs. The list below is honest about both the common and the serious.

Common Side Effects of Insulin Glargine

The side effects most often reported with Insulin Glargine:

  • Hypoglycemia — the central risk of insulin therapy; monitor blood glucose and learn to recognize early symptoms.
  • Weight gain — monitor and discuss with your clinician if it persists or worsens.
  • Injection-site reactions — usually minor redness or itching; rotating injection sites helps.

These tend to be dose-related. They are most prominent during dose escalation and typically improve once the body adapts to a steady dose.

Serious Risks

Less common but important:

  • Severe hypoglycemia — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.
  • Diabetic ketoacidosis if dosing is interrupted in T1D — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.

Insulin Glargine should not be used if you have: hypoglycemia.

How to Manage Common Side Effects

Track what you feel. Side effects are easier to discuss when you have a record of when they appear and how severe they are.

Don't change the dose on your own. Many side effects improve with time at a steady dose; stopping and restarting often resets the adaptation period.

Stay hydrated and eat regularly. Generic advice that nonetheless prevents many otherwise-avoidable side-effect calls.

Communicate with your clinician. Most side effects have a management strategy; the worst outcomes happen when people stop the drug silently and don't get the next-step plan.

For dose-titration questions, see our Insulin Glargine dosage guide.

Side Effects vs. Withdrawal Effects

It's worth distinguishing between side effects (from taking the drug) and withdrawal or rebound effects (from stopping it). For Insulin Glargine, the most relevant rebound concern is compound-specific — see the prescribing information.

When to Stop and Call Someone

These symptoms warrant prompt clinical evaluation:

  • Severe abdominal pain (especially radiating to the back) — possible pancreatitis
  • Vision changes
  • Signs of allergic reaction (hives, throat tightness, difficulty breathing)
  • Severe vomiting or dehydration
  • Severe hypoglycemia

Side Effects in Context

Most people who take Insulin Glargine experience some side effects. Most of those are tolerable and improve with time. The decision to continue is a balance between benefit and tolerance, made together with a clinician.

For people weighing whether Insulin Glargine is the right fit, our Insulin Glargine results page covers the upside.

Bottom Line

Side effects on Insulin Glargine are part of the trade-off, not a sign you're doing something wrong. The honest read is that most are tolerable and most improve.

Frequently Asked Questions

Frequently Asked Questions

Sources

This page is informational only and is not medical advice. Stop Insulin Glargine and seek medical attention if you experience severe symptoms.

Last updated: 2026-04-29 · For informational purposes only. Consult a healthcare provider.